Acute organ transplant rejection is characterized by a heavy lymphocyte infiltration. We have previously shown that alterations in the graft endothelium lead to increased lymphocyte traffic into the graft. Here, we demonstrate that lymphocytes adhere to the endothelium of rejecting cardiac transplants, but not to the endothelium of syngeneic grafts or normal hearts analyzed with the in vitro Stamper-Woodruff binding assay. Concomitant with the enhanced lymphocyte adhesion, the cardiac endothelium begins to de novo express sialyl Lewis a and sialyl Lewis x (sLea and sLex) epitopes, which have been shown to be sequences of L-selectin counterreceptors. The endothelium of allografts, but not that of syngeneic grafts or normal controls, also reacted with the L-selectin-immunoglobulin G fusion protein, giving further proof of inducible L-selectin counterreceptors. The lymphocyte adhesion to endothelium could be significantly decreased either by treating the iymphocytes with anti-L-selectin antibody HRL-1, or by treating the tissue sections with sialidase or anti-sLea or anti-sLex monoclonal antibodies. Finally, we synthetized enzymatically several members of the sLex family oligosaccharides and analyzed their ability to block lymphocyte adhesion to cardiac endothelium. The monovalent sLex (a tetramer), divalent sLex (a decamer), and tetravalent sLex (a 22-mer) could all significantly reduce lymphocyte binding, but the inhibition by the tetravalent sLex-construct was clearly superior to other members of the sLex family. The crucial control oligosaccharides, sialyl lactosamines lacking fucose but being otherwise similar to the members of sLex family, had no effect on lymphocyte binding.
L
Ymphocyte extravasation is initiated by the interaction of members of the selectin family and their oligosaccharide-containing counterreceptors (1) (2) (3) (4) (5) . L-selectin is solely expressed on leukocytes and recognizes an endothelial counterreceptor that is at least c~2,3-sialylated, c~l,3/4-fucosylated, and contains sulfate group(s) (6) (7) (8) (9) (10) . Three mucinlike heavily O-glycosylated proteins, GlyCAM-1, CD34, and MAdCAM-1, which participate in the L-selectindependent adhesion, have been cloned (11) (12) (13) (14) . High endothelial cells in peripheral lymph nodes express sialyl Lewis a and sialyl Lewis x (sLea and sLex, respectively) 1 epitopes *Abbreviations used in this paper: sLea, sialyl Lewisa; sLex, sialyl LewisX; sLN, sialyl lactosamine. (15) (16) (17) , which are parts of the L-selectin counterreceptor. The endothelial cells in several other locations are sLea and sLex negative, but inflammatory stimuli can induce previously negative endothelium to express these oligosaccharide structures de novo (18) . We have also shown that cultured endothelial cells possess the machinery to generate at least sLex, since they have several functional 0e2,3 sialyl-and c11,3 fucosyltransferases, enzymes involved in generating sLex from (poly)lactosamines (19) .
Heart transplant rejection is characterized by a heavy infiltration of lymphocytes into the graft (20) (21) (22) . Here, we show that rat cardiac endothelium, which does not express sLea and sLex in normal animals, can be induced to express these oligosaccharide epitopes during transplant rejection episodes. This de novo expression of sialylated Lewis oli-gosaccharides leads to enhanced lymphocyte adhesion to endothelium in a sLea-, sLex-, and L-selectin-dependent manner. The endothelium of rejected heart grafts, but not that of normal hearts or syngeneic grafts, stains directly with the L-selectin-IgG fusion protein. We have synthetized mono-, di-, and tetravalent sLex oigosaccharides and their corresponding sialyl lactosamine (sLN) constructs lacking fucose. Our results show that the tetravalent sLex (a 22-mer oligosaccharide) is superior in inhibiting the L-selectin-dependent lymphocyte adhesion to heart endothelium compared to di-or monovalent sLex oligosaccharides (a deca-and tetramer, respectively). On the contrary, the sLN oligosaccharides did not have any effect on lym'-phocyte adhesion. Taken together, these data suggest that the upregulation of the endothelial expression of sLea and sLex is of crucial importance in the generation of L-selectin-dependent lymphocyte inflammation in the rejecting cardiac allograft, and that soluble oligosaccharides can inhibit this process.
Material and Methods
Rats and Transplantations. Inbred WF (R.T1 v) and DA (RT1 a) rat strains were carried in our own colony and regularly tested for intrastrain acceptance of cardiac and renal transplants, as well as for the absence of intrastrain mixed lymphocyte culture. 10-12-wk-old rats were used for the transplantations, and a modified microvascular technique was used (22) . The DA hearts that were transplanted into WF recipients were allografts, WF grafts to WF and DA grafts to DA served as syngeneic controls, and normal nontransplanted hearts served as controls.
Stamper-Woodruff Binding Assay. Syngeneic (DA to DA and WF to WF) and allogeneic (DA to WF) transplants were removed on day 3 after the transplantations. Small pieces of the removed hearts were mounted in Tissue Tek medium (Lab-Tek Productions, Naperville, IL) and snap-frozen in liquid nitrogen. 8-~m-thick frozen sections were prepared within 1 h before the use of the sections in the lymphocyte-endothelium binding assay (23) . Single-cell suspensions ofmesenteric lymph node lymphocytes were made by mechanical disaggregation in R.PMI 1640 medium (GIBCO BRL, Bethesda, MD) supplemented with Hepes (25 raM) and 0.5% FCS and the cells were passed through a 50-~m pore size mesh. Lymphocyte purity was >99%, and the population consisted of 80-90% CD3-positive T cells, 50-60% CD4-positive T cells, 25-35% CD8-positive T cells, and 10-20% CD19-positive B cells, as analyzed by flow cytometric analyses and immunoperoxidase stainings from cytocentrifuge preparations.
3 X106 cells in 100 pA of the medium were plated on top of the tissue sections using a wax pen circle to avoid escape of the fluid. The sections were rotated horizontally on a shaker at 60 rpm for 30 rain at +4~ After incubation, the medium was gently tapped away by an absorbent paper and the slides were fixed in 1.5% cold glutaraldehyde overnight. The slides were stained with thionine for 30 rain. The excess thionine was gently washed away using PBS, and the slides were mounted with PBS-glycerol (1:1) or Aquamount Mountant (BHD Ltd., Poole, UK). The number oflymphocytes bound to various heart structures was determined from these preparations.
mAbs and Fusion Proteins. The characterization of two hamster anti-rat L-selectin mAbs, one blocking (HRL1) and the other one not blocking adhesion (HRL2), has been published (24, 25) . The generation of PVR-Ig and L-selectin-IgG fusion proteins has also been documented (24, 25 ImmunohistochemicaI Stainings. The immunoperoxidase stainings for frozen sections were performed with routine specimens after acetone fixation for 10 min at 4~ The stainings with fusion proteins were performed as previously described (24, 25) . In short, frozen sections were fixed in 1% paraformaldehyde, pH 7.3, for 20 rain at 4~ followed by incubation in 100% methanol with 0.3% H202 to eliminate endogenous peroxidase for 20 rain at 4~ The sections were then washed in PBS and were incubated for 60 rain at 4~ with 1-10 ~g of either PVR.-Ig or L-selectin-IgG fusion proteins diluted in PBS containing 5% FCS. Then the sections were washed and incubated with biotinylated goat anti-human IgG (Zymed Laboratories, San Francisco, CA) in PBS containing 5% FCS for 30 rain at 21~ The sections were incubated with 3-amino-9-ethyl carbatzole and H202 for 10 rain, washed, counterstained with hematoxylin, and mounted with Aquamount mountant (BDH Ltd.) for light microscopic analyses.
Enzymatic Synthesis of sLex Oligosaccharides. Synthesis of the Lex trisaccharide has been described previously (26) . For construction of the monovalent sLex tetrasaccharide, the divalent sLex decasaccharide, and the tetravalent sLex 22-saccharide N-acetyllactosamine, the hexasaccharide Gal~-4GlcNAc Gal and the tetradecasaccharide Ga1131-3 were used, respectively, as primers. The acceptors were first ~x2,3-sialylated by incubating them exhaustively with CMP-NeuNAc and ~x2,3-sialyltransferase from human placenta. The isolated, fully sialylated saccharides were then od,3 fucosylated exhaustively with GDP-Fuc and a partially purified preparation of human milk cll,3-fucosyltransferase(s) (26) . The sample sizes were estimated by UV absorption against external N-acetylglucosamine. The characterization of the constructs was carried out by ion exchange chromatography, matrix-assisted laser desorption ionization mass spectrometry, and one-dimensional 1H nuclear magnetic resonance spectroscopy at 500 MHz.
Results

Endothelium in Rejecting Cardiac Transplants Adheres More Lymphocytes than Normal Endothelium.
To analyze the role of lymphocyte extravasation during rejection episodes, we performed MHC-incompatible allogeneic transplantations between inbred rat stains DA to WF. Control syngeneic transplantations were performed within DA or WF strains In the syngeneic grafts and in (c) allografts, the number of bound lymphocytes is also at a very low level. The same observation was made in arterioles; these structures in normal hearts (d) practically did not adhere lymphocytes at all, and the binding in syngeneic grafts (e) and allografts ~ was at a very low level. Venules (dashed line) from normal hearts (g) and syngeneic grafts (h) adhered only a few lymphocytes, but on the contrary, the venules in the allografts (0 adhered an increased number oflymphocytes. Intermuscular capillaries adhered some lymphocytes in the normal tissue 0) and in the syngeneic grafts (k). (/) There was a clear enhancement in the lymphocyte adherence to intermuscular capillaries in the allografts. A large number of cross and longitudinal sections of intermuscular capillaries are seen in this panel, and only a few of the lymphocytes adhering to these structures are marked by arrows. Note that in all panels there are also some lymphocytes adhering directly on top of the myocardium that are not lying on top of any endothelial structures (a and l, white arrows).
(from D A to D A or from W F to W F strains), and normal hearts (from D A and W F ) were used as negative controls. T h e hearts were r e m o v e d o n day 3 w h e n the rejection had just started, frozen sections were cut, and the Stamper-W o o d r u f f l y m p h o c y t e adhesion assay was performed.
In sections prepared from syngeneic grafts o f normal hearts, e n d o t h e l i u m in the tissue sections prepared from allografts b o u n d significantly more lymphocytes than to the e n d o t h e l i u m (Table 1 and Fig. 1 ). W h e n the anatomical location was analyzed in more detail, the e n d o t h e l i u m was divided into several categories according to the size of the vascular structure: (a) endocardium, (b) arterioles, (c) v e nules, and (d) intermuscular capillaries. Lymphocyte adhesion was assayed in these various compartments and, it was found to be increased onto the intermuscular capillaries and venules during rejection (Table 1 and Fig. 1 ). There was a constant low background b i n d i n g of lymphocytes to the m y o c a r d i u m in all heart specimens. The mean -+ SEM of seven independent experiments is presented.
T T h e data presented above indicate that the inflammation associated with acute rejection induced proadhesive properties to the graft endothelium. Since the selectin-mediated rolling has been suggested to be the primary event in the cascade leading to leukocyte extravasation, w e focused on molecules putatively taking part in the generation o f l y m p h o c y t e infiltration in the rejected heart grafts. L-selectin has at least three heavily glycosylated mucin-like protein counterreceptors, GlyCAM-1, CD34, and MAd-CAM-1 (11) (12) (13) (14) . In vitro assays have also pointed out the crucial role of sialylated, fucosylated, and sulfated oligosaccharides in L-selectin-dependent adhesion (6) (7) (8) (9) (10) . W e therefore analyzed whether the endothelium would express sialyl Lewis epitopes containing ix2,3-sialylated and cil,3/ 4-fucosylated oligosaccharides. As shown in Table 2 , the endothelium in normal hearts and syngeneic grafts did not react with anti-sLea and -sLex mAbs (Ca19.9, IgG1 and CSLEX-1, IgM respectively). On the contrary, all endothelial structures in allografts undergoing rejection expressed sLea and sLex epitopes; the venules and intermuscular capillaries being most reactive (Table 2 and Fig. 2) . Concomitantly, isotype-matched control mAbs against E-selectin (IgG1), as well as Lex and Lea (IgM), were negative in normal hearts, as well as in syngeneic and allogeneic grafts (Table 2 and data not shown).
Furthermmore, stainings performed with L-selectin-IgG fusion protein also demonstrate endothelial reactivity in venules and intermuscular capillaries only in allografts, but not in syngeneic grafts or normal hearts (Table 3 and Fig.  2 ). In clear contrast, stainings with control P V R -I g fusion protein were negative in all heart tissues. The reactivity with L-selectin-IgG fusion protein and anti-sLea and -sLex antibodies could be removed from the allografts by preincubating the tissue sections with sialidase ( Fig. 2 and data  not shown) .
Anti-L-Selectin as Well as Anti-sLea and -sLex Antibodies Inhibit Lymphocyte Adhesion to the Endothelium of Rejecting
Cardiac Transplants. To provide evidence for the direct role of L-selectin in the lymphocyte adhesion to cardiac endothelium, we performed the Stamper-Woodruff binding assay using lymphocytes incubated with anti-L-selectin mAbs before placing them into the binding assay. The lymphocyte binding to syngeneic grafts was only slightly above the control levels (Table 1) , and this binding could not be significantly modified by anti-L-selectin, -sLea, or -sLex antibodies (data not shown). On the contrary, the anti-L-selectin mAb HRL-1, shown to recognize a functional epitope, decreased the lymphocyte adherence to allograft tissue down to 37% compared to the nontreated control (Fig. 3) . Concomitantly, HRL-2, which is a non-function-blocking anti-L-selectin antibody, had no effect. T o show that the de novo-induced endothelial oligosaccharide expression on allograft endothelium was involved in the increased lymphocyte adhesion, we used anti-sLea and -sLex mAbs as inhibitors of adhesion. When the tissue sections prepared from the allografts were incubated with anti-sLea or -sLex antibodies, the lymphocyte adhesion to aUografts decreased down to 24 and 38%, respectively (Fig. 3) . When the two approaches were used simultaneously, i.e., lymphocytes were treated with the function-blocking anti-L-selectin HRL-1 and the tissue sections were treated with anti-sLea, the lymphocyte adhesion was decreased to background levels (Fig. 3) . As a negative control, the tissue sections were incubated with an isotype-matched anti-MHC class lI antibody, which reacted with the endothelium but had no effect on the lymphocyte binding. Table 3 . 
Reactivity of Various Anatomical Structures on Normal Hearts and on Syngeneic or Allogeneic Heart Grafts on Day 3 after Transplantation Stained with Either the Control PVR-Ig-or the L-section-Ig Fusion Protein
All Enzymatically Synthesized sLex-type Oligosaccharides Inhibit Lymphocyte Adhesion to the Endothelium of Rejecting Cardiac Transplants but Tetravalent sLex is Most
Potent. Finally, we tested the possibility of inhibiting the lymphocyte adhesion to the cardiac endothelium during acute rejection episodes by oligosaccharides. We generated the following family of oligosaccharides by enzyme-aided synthesis: monovalent sLex tetrasaccharide, divalent sLex decasaccharide, and tetravalent sLex 22-mer oligosaccharide, as well as their nonfucosylated sialyl lactosamine analogues (Fig. 4) . The structures of these glycans were verifed by chromatography, one-dimensional nuclear magnetic resonance, and mass spectroscopy. The lymphocytes were preincubated for 30 rain with various concentrations of the oligosaccharides and used thereafter in the Stamper-Woodruffbinding assay in the incubation media. These oligosaccharides did not significantly alter the lymphocyte binding to syngeneic grafts, which was only slightly above the binding to normal heart tissue ( Table 1 and data not shown). On the other hand, all members of the sLex family were effective in inhibiting lymphocyte adhesion to cardiac endothelium, but the tetravalent sLex was clearly superior compared to the other sLex oligosaccharides (Fig. 5) . Concomitantly, the nonfucosylated sLN glycans remained without effect.
Discussion
We show in this paper that normal cardiac endothelium does not express sLea or sLex oligosaccharides present in L-selectin counterreceptors and concomitantly does not support lymphocyte adhesion. On the contrary, during acute graft rejection, the cardiac endothelium began to express both of these sialylated Lewis epitopes and to support lymphocyte adhesion. Furthermore, the cardiac endothelium stains in a sialidase-sensitive manner with the L-selectin-IgG fusion protein during acute rejection episodes. The lymphocyte adhesion to graft endothelium was inhibited by treating the endothelium either with sialidase or antisLea or -sLex mAbs. Adhesion was also inhibited by treating the lymphocytes with anti-L-selectin mAb or sLexbearing oligosaccharide constructs. All this points to the crucial role of L-selectin--sLea-, and sLex-dependent lymphocyte extravasation into cardiac allografts during acute rejection.
Acute organ allograft rejections are characterized by a heavy infiltration of lymphocytes (20, 21) . Since the hallmark of rejection is lymphocytosis in the graft, the essential task in preventing rejection would be to prevent the entry of lymphocytes into the grafts. A number of studies have indicated that the level of expression of endothelial adhesion molecules intracellular adhesion molecule-I, vascular cell adhesion molecule-I, and E-selectin increase during cardiac rejection (29) (30) (31) (32) . Likewise, the direct use of antibodies against these adhesion molecules or their counterreceptors has demonstrated that they are involved in the lymphocyte infiltration (33) . The current concept in lymphocyte extravasation, however, is that the cells must first roll on the endothelium via a selectin-carbohydrate-mediated interaction before they can adhere with integrins (1-5, 34, 35) . Since the majority of lymphocytes do not possess counterreceptors for E-or P-selectins (36, 37), we sought evidence for L-selectin being involved in the primary rolling leading to lymphocyte infiltration into the heart transplants.
Endothelial expression of L-selectin counterreceptors is very restricted (38, 39) . We and others have shown that the high endothelium in the peripheral but not in the mucosal lymph nodes express sLex and sLea oligosaccharides (15) (16) (17) . In peripheral lymph nodes, the high endothelium supports L-selectin-dependent lymphocyte adhesion, expresses specific glycoforms of CD34, and secretes GlyCAM-1 (11, 13, 14) . The routine GlyCAM-1 glycoprotein from peripheral lymph nodes is decorated by sulfated sLex oligosaccharides (40) .
Our assays do not answer whether the sLea and sLex epitopes on the endothelium are on protein or lipid backbones, but they demonstrate that the expression of these epitopes is strongly upregulated during inflammation. How is then the sLea and sLex expression induced to endothelial cells? We have shown that cultured endothelial cells ex-press sLex and have several functional ot2,3 sialyl-and o~1,3 fucosyltransferases, which are able to sialylate and fucosylate distal N-acetyl lactosamine sequences, thus generating sLex epitopes (19) . These endothelial enzyme activities can be enhanced in vitro by inflammatory cytokines such as TNF (19) . Thus, our previous results indicate that endothelial cells have the machinery for generating sialylated Lex epitopes in an inflammation-regulated manner. A complementary mechanism could involve passive absorption of sLea and sLex from blood circulation by endothelial cells (16) , but even this process should be inducible by inflammation.
The question of rodent tissues expressing sLex type of oligosaccharides is a controversial one. There is evidence that rodent leukocytes do not express sLex (41) . Murine GlyCam-1 secreted by lymph node endothelium, however, does bear sulfated sLex epitopes (40) and we have previously shown that peritubular capillary endothelium on rat kidney allografts starts to de novo express sLex during rejection (18) . So, it may well be that sLex-type oligosaccharides are not expressed on rodent leukocytes, or that they are modifications that do not react with the presently available anti-sLex mAbs. The sLex-type structures in the endothelium of lymph nodes or inflamed tissues of these animals, however, do react with the same mAbs.
The induction of endothelial sialyl Lewis epitopes at sites of inflammation and their crucial role in L-selectin-dependent lymphocyte extravasation leads to the tempting possibility of blocking the generation of inflammation with oligosaccharides. Some published reports show that monovalent sLex tetrasaccharide is able to block the P-selectindependent accumulation of granulocytes in models involving lung inflammation or cardiac reperfusion (42, 43) . In vitro data suggests also that oligosaccharide constructs bearing two sLex groups (divalent sLex structures) are five times better inhibitors of E-selectin-dependent adhesion compared to monovalent sLex (44, 45) . Although the generation of very complex oligosaccharides has been difficult, enzyme-aided synthesis makes it possible at this time (28) . We have constructed enzymatically a family of sLex oligosaccharides in quantities sufficient for in vitro binding assays. We could show that the tetravalent sLex was clearly superior in blocking the lymphocyte adhesion to cardiac endothelium compared to mono-or divalent sLex. Quite small concentrations (50 nM) were needed for the inhibitory effects, suggesting that the amounts of oligosaccharides required in preventing inflammation even in vivo will not be out of reach.
Taken together, the present data show that endothelial sLea and sLex expression are strongly induced in endothelium at sites of inflammation, such as organ allograft rejection. Furthermore, this expression of sialylated Lewis epitopes is correlated to L-selectin-dependent lymphocyte adhesion to endothelium as a prelude to extravasation. We predict that direct in vivo use of anti-sLea, -sLex, or -L-selectin antibodies, or even better, of competing oligosaccharide constructs, will inhibit lymphocyte entry into allografts and prevent rejection.
